Alan Rosen

4.5k total citations
133 papers, 2.8k citations indexed

About

Alan Rosen is a scholar working on Clinical Psychology, General Health Professions and Psychiatry and Mental health. According to data from OpenAlex, Alan Rosen has authored 133 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Clinical Psychology, 58 papers in General Health Professions and 44 papers in Psychiatry and Mental health. Recurrent topics in Alan Rosen's work include Mental Health Treatment and Access (41 papers), Schizophrenia research and treatment (39 papers) and Psychiatric care and mental health services (38 papers). Alan Rosen is often cited by papers focused on Mental Health Treatment and Access (41 papers), Schizophrenia research and treatment (39 papers) and Psychiatric care and mental health services (38 papers). Alan Rosen collaborates with scholars based in Australia, United States and Denmark. Alan Rosen's co-authors include Gordon Parker, Dušan Hadži-Pavlović, Garry Walter, Maree Teesson, John Hoult, Jane Pirkis, Tim Coombs, Tom Callaly, Ingrid Reynolds and John Hambridge and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal of Psychiatry.

In The Last Decade

Alan Rosen

125 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Rosen Australia 29 1.4k 1.2k 1.1k 906 247 133 2.8k
Jocelyn Catty United Kingdom 28 1.4k 1.0× 1.3k 1.1× 1.2k 1.1× 915 1.0× 204 0.8× 51 2.7k
Daniel Chisholm United Kingdom 29 972 0.7× 799 0.7× 892 0.8× 955 1.1× 178 0.7× 62 2.7k
Marit Borg Norway 25 1.4k 1.0× 2.0k 1.7× 591 0.6× 688 0.8× 292 1.2× 122 2.8k
Steven P. Segal United States 32 1.5k 1.1× 1.4k 1.2× 589 0.6× 666 0.7× 152 0.6× 139 2.8k
Carlos Nordt Switzerland 24 1.9k 1.3× 860 0.7× 775 0.7× 1.6k 1.8× 177 0.7× 69 3.2k
Trevor R. Hadley United States 31 1.5k 1.0× 1.8k 1.6× 950 0.9× 521 0.6× 130 0.5× 102 3.8k
Aliya Kassam Canada 22 1.1k 0.8× 1.2k 1.0× 495 0.5× 1.5k 1.6× 110 0.4× 73 2.7k
Patricia E. Deegan United States 22 1.5k 1.1× 2.8k 2.4× 1.0k 1.0× 773 0.9× 784 3.2× 42 3.7k
Beate Schulze Germany 18 1.6k 1.1× 813 0.7× 724 0.7× 1.7k 1.9× 200 0.8× 42 2.7k
Leona L. Bachrach United States 31 1.5k 1.1× 1.7k 1.4× 1.0k 1.0× 905 1.0× 460 1.9× 118 3.2k

Countries citing papers authored by Alan Rosen

Since Specialization
Citations

This map shows the geographic impact of Alan Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Rosen more than expected).

Fields of papers citing papers by Alan Rosen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Rosen. The network helps show where Alan Rosen may publish in the future.

Co-authorship network of co-authors of Alan Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Rosen. A scholar is included among the top collaborators of Alan Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Rosen. Alan Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willis, Brandon S., Hannah Dry, Wendan Xu, et al.. (2024). Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma. Leukemia. 38(12). 2663–2674. 2 indexed citations
2.
Salinas-Pérez, José A., Mencía R. Gutiérrez-Colosía, Carlos R. García‐Alonso, et al.. (2023). Patterns of mental healthcare provision in rural areas: A demonstration study in Australia and Europe. Frontiers in Psychiatry. 14. 993197–993197. 3 indexed citations
3.
Rosenberg, Sebastian, Luis Salvador‐Carulla, & Alan Rosen. (2023). Mental health reform in Australia – unfinished business. BJPsych International. 20(4). 99–101. 2 indexed citations
4.
Rosen, Alan, et al.. (2022). Co-leadership to co-design in mental health-care ecosystems: what does it mean to us?. Leadership in health services. 36(1). 59–76. 7 indexed citations
5.
El‐Den, Sarira, Rebekah Moles, Andrea Murphy, et al.. (2022). Exploring the impact of suicide care experiences and post-intervention supports sought among community pharmacists: a cross-sectional survey. International Journal of Clinical Pharmacy. 44(6). 1247–1258. 8 indexed citations
6.
Gill, Neeraj, et al.. (2020). Human rights implications of introducing a new mental health act – principles, challenges and opportunities. Australasian Psychiatry. 28(2). 167–170. 4 indexed citations
7.
Atkinson, Stephen R., Ghil’ad Zuckermann, Graham Gee, et al.. (2019). “Language Breathes Life”—Barngarla Community Perspectives on the Wellbeing Impacts of Reclaiming a Dormant Australian Aboriginal Language. International Journal of Environmental Research and Public Health. 16(20). 3918–3918. 29 indexed citations
8.
Murphy, Andrea, Claire L. O’Reilly, Alan Rosen, et al.. (2018). Community pharmacists’ experiences and people at risk of suicide in Canada and Australia: a thematic analysis. Social Psychiatry and Psychiatric Epidemiology. 53(11). 1173–1184. 31 indexed citations
9.
Robertson, Michael D., Philip Boyce, Terry Carney, et al.. (2016). How shortcomings in the mental health system affect the use of involuntary community treatment orders. Australian Health Review. 41(3). 351–356. 15 indexed citations
10.
Kerridge, Ian, Michael J. Robertson, Philip Boyce, et al.. (2015). Involuntary psychiatric treatment in the community: general practitioners and the implementation of community treatment orders.. PubMed. 44(7). 485–9. 5 indexed citations
11.
Robertson, Michael, Alan Rosen, Terry Carney, et al.. (2013). Risk, Capacity and Making Decisions about CTOs: A Report From 'The CTO Study''. eCite Digital Repository (University of Tasmania). 1 indexed citations
12.
Rosen, Alan, et al.. (2012). The future of community-centred health services in Australia: ‘When too many beds are not enough’. Australian Health Review. 36(3). 239–243. 6 indexed citations
13.
Shiers, David, et al.. (2009). Beyond early intervention: can we adopt alternative narratives like ‘Woodshedding’ as pathways to recovery in schizophrenia?. Early Intervention in Psychiatry. 3(3). 163–171. 12 indexed citations
14.
Rosen, Alan. (2007). Return from the vanishing point: a clinician's perspective on art and mental illness, and particularly schizophrenia. Epidemiologia e Psichiatria Sociale. 16(2). 126–132. 4 indexed citations
15.
Rosen, Alan, Kim T. Mueser, & Maree Teesson. (2007). Assertive community treatmentIssues from scientific and clinical literature with implications for practice. The Journal of Rehabilitation Research and Development. 44(6). 813–813. 56 indexed citations
16.
17.
Rosen, Alan & Tom Callaly. (2005). Interdisciplinary teamwork and leadership: issues for psychiatrists. Australasian Psychiatry. 13(3). 234–240. 36 indexed citations
18.
Stein, Leonard I., Ronald J. Diamond, & Alan Rosen. (2003). Assertive community treatment. The Psychiatrist. 27(4). 155–155. 1 indexed citations
19.
Newton, Lisa H., Alan Rosen, Chris Tennant, & Charlotte A. Hobbs. (2001). Moving out and moving on: Some ethnographic observations of deinstitutionalization in an Australian community.. Psychiatric Rehabilitation Journal. 25(2). 152–162. 11 indexed citations
20.
Rosen, Alan, et al.. (2000). Threshold Assessment Grid (TAG): the development of a valid and brief scale to assess the severity of mental illness. Social Psychiatry and Psychiatric Epidemiology. 35(2). 78–85. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jocelyn Catty Breakdown of academic impact, for papers by Daniel Chisholm Breakdown of academic impact, for papers by Marit Borg Breakdown of academic impact, for papers by Steven P. Segal Breakdown of academic impact, for papers by Carlos Nordt Breakdown of academic impact, for papers by Trevor R. Hadley Breakdown of academic impact, for papers by Aliya Kassam Breakdown of academic impact, for papers by Patricia E. Deegan Breakdown of academic impact, for papers by Beate Schulze Breakdown of academic impact, for papers by Leona L. Bachrach
Rankless by CCL
2026